Dagmar Hornung

Quality of life, effectiveness and patient reported outcomes of antiemetic prophylaxis with NEPA within the German NIS AkyPRO: post-hoc analysis of patients receiving carboplatin-based chemotherapy

Joerg Peter Schilling, Gabriele Kaltenecker, Rebecca Ann Lorenz, Eberhard Müller et autres

Purpose Carboplatin is classified as moderate emetogenic, but shows a higher incidence of chemotherapy (CT)- induced nausea and vomiting (CINV). We present a post-hoc analysis of effectiveness, quality of life (QoL) and patient reported outcomes (PRO) of CINV prevention with NEPA, the …

de, ee (code pays fourni par la source)

278 Real-life data on gynecological sarcoma – therapeutic strategies for primary treatment – results of the german sarcoma registry REGSA (NOGGO RU1)

Eva Roser, Felix Schmidt, Dario Zocholl, Lars Hanker et autres

de (code pays fourni par la source)

MBCL-11. TIME TO RADIOTHERAPY IMPACTS SURVIVAL IN PEDIATRIC AND ADOLESCENT NON-METASTATIC MEDULLOBLASTOMA TREATED BY UPFRONT RADIOTHERAPY – A REPORT FROM THE HIT 2000 TRIAL

Stefan Dietzsch, Felix Placzek, Klaus Pietschmann, Andre Oscar von Bueren et autres

Abstract PURPOSE To evaluate prognostic factors and impact of participation in a randomized trial in non-metastatic medulloblastoma. METHODS AND PATIENTS 382 patients with non-metastatic medulloblastoma aged 4–21 years with primary neurosurgical resections between 2001 and 2011 were enrolled into the HIT 2000 …

de, ch, at, gb (code pays fourni par la source)

Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial

Stefan Dietzsch, Felix Placzek, Klaus Pietschmann, Andre Oscar von Bueren et autres

PurposeWe aimed to compare treatment results in and outside of a randomized trial and to confirm factors influencing outcome in a large retrospective cohort of nonmetastatic medulloblastoma treated in Austria, Switzerland and Germany.Methods and MaterialsPatients with nonmetastatic medulloblastoma (n = 382) aged …

de, ch, at, gb (code pays fourni par la source)

Quality of life, effectiveness and patient reported outcomes of antiemetic prophylaxis with NEPA within the German NIS AkyPRO: post-hoc analysis of patients receiving carboplatin-based chemotherapy

J Schilling, R Lorenz, Daniela Rezek, L Bauer et autres

Purpose Carboplatin is classified as moderate emetogenic, but shows a higher incidence of chemotherapy (CT)- induced nausea and vomiting (CINV). We present a post-hoc analysis of effectiveness, quality of life (QoL) and patient reported outcomes (PRO) of CINV prevention with NEPA, the …

de, ee (code pays fourni par la source)

Quality of life, effectiveness and patient reported outcomes of antiemetic prophylaxis with NEPA within the German NIS AkyPRO: post-hoc analysis of patients receiving carboplatin-based chemotherapy

Joerg Peter Schilling, Rebecca Ann Lorenz, Daniela Rezek, L Bauer et autres

Purpose Carboplatin is classified as moderate emetogenic, but shows a higher incidence of chemotherapy (CT)- induced nausea and vomiting (CINV). We present a post-hoc analysis of effectiveness, quality of life (QoL) and patient reported outcomes (PRO) of CINV prevention with NEPA, the …

de, ee (code pays fourni par la source)

Adressen

Matthias Karl Bernhard, Rainer Blank, Simon Dulz, Friedrich Ebinger et autres

A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.

Dirk Rades, Liesa Dziggel, Stefan Janssen, Oliver Blanck et autres

AIM: To generate a survival score for patients with breast cancer treated with stereotactic radiosurgery (SRS) alone for brain metastases. PATIENTS AND METHODS: Seven factors were evaluated in 34 patients, namely age, performance score, number of brain metastases, maximum diameter of all …

de, us (code pays fourni par la source)

Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer.

Liesa Dziggel, Markus Dahlke, Stefan Janssen, Dagmar Hornung et autres

AIM: To generate a tool that estimates the probability of developing new cerebral metastases after stereotactic radiosurgery (SRS) in breast cancer patients. PATIENTS AND METHODS: SRS dose plus seven characteristics (age, performance score, number of cerebral metastases, maximum diameter of all metastases, …

de, vn, us (code pays fourni par la source)

A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.

Dirk Rades, Markus Dahlke, Niklas Gebauer, Tobias Bartscht et autres

AIM: To develop a predictive tool for survival after stereotactic radiosurgery of brain metastases from colorectal cancer. PATIENTS AND METHODS: Out of nine factors analyzed for survival, those showing significance (p<0.05) or a trend (p≤0.06) were included. For each factor, 0 (worse …

de, vn (code pays fourni par la source)

3317 Treating brain metastases in malignant melanoma - Should whole brain radiation be a part of it?

John C. Schmitz, Noa Judith Freudenthal, Tobias Gauer, Silke Tribius et autres

Number of cerebral lesions predicts freedom from new brain metastases after radiosurgery alone in lung cancer patients

Dirk Rades, Stefan Huttenlocher, Mai Trong Khoa, Dagmar Hornung et autres

Numerous patients with few brain metastases receive radiosurgery, either alone or in combination with whole-brain irradiation. The addition of whole-brain irradiation to radiosurgery reduces the rate of intracerebral failures, particularly the development of new cerebral lesions distant from those treated with radiosurgery. …

de, vn, us (code pays fourni par la source)